Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia

Joan Cunningham, Alice Rumbold, Xiaohua Zhang, John R. Condon

Research output: Contribution to journalReview article

128 Citations (Scopus)

Abstract

An assessment of recent data on cancer in Indigenous Australians (Aborigines and Torres Strait Islanders) shows that, although they are less likely to have some types of cancer than other Australians, Indigenous people are significantly more likely to have cancers that have a poor prognosis, but are largely preventable, such as lung and liver cancer. Indigenous people with cancer are diagnosed at a later stage, are less likely to receive adequate treatment, and are more likely to die from their cancers than other Australians. Inadequate identification of Indigenous people in cancer registers precludes reporting for some parts of Australia, but sufficient information is available to identify priorities and inform appropriate remedial action. Health-risk factors, especially smoking, and inadequate health-system performance largely explain the patterns of cancer incidence and mortality in areas with adequate data. Effective tobacco control programmes, improvements across a range of health services, and meaningful Indigenous engagement are all needed to decrease the burden of cancer in Indigenous Australians.

LanguageEnglish
Pages585-595
Number of pages11
JournalThe Lancet Oncology
Volume9
Issue number6
DOIs
Publication statusPublished - 1 Jun 2008
Externally publishedYes

ASJC Scopus subject areas

  • Oncology

Cite this

Cunningham, Joan ; Rumbold, Alice ; Zhang, Xiaohua ; Condon, John R. / Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. In: The Lancet Oncology. 2008 ; Vol. 9, No. 6. pp. 585-595.
@article{292b88c2a41c4bd48433b59cc9516e5c,
title = "Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia",
abstract = "An assessment of recent data on cancer in Indigenous Australians (Aborigines and Torres Strait Islanders) shows that, although they are less likely to have some types of cancer than other Australians, Indigenous people are significantly more likely to have cancers that have a poor prognosis, but are largely preventable, such as lung and liver cancer. Indigenous people with cancer are diagnosed at a later stage, are less likely to receive adequate treatment, and are more likely to die from their cancers than other Australians. Inadequate identification of Indigenous people in cancer registers precludes reporting for some parts of Australia, but sufficient information is available to identify priorities and inform appropriate remedial action. Health-risk factors, especially smoking, and inadequate health-system performance largely explain the patterns of cancer incidence and mortality in areas with adequate data. Effective tobacco control programmes, improvements across a range of health services, and meaningful Indigenous engagement are all needed to decrease the burden of cancer in Indigenous Australians.",
author = "Joan Cunningham and Alice Rumbold and Xiaohua Zhang and Condon, {John R.}",
year = "2008",
month = "6",
day = "1",
doi = "10.1016/S1470-2045(08)70150-5",
language = "English",
volume = "9",
pages = "585--595",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "6",

}

Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. / Cunningham, Joan; Rumbold, Alice; Zhang, Xiaohua; Condon, John R.

In: The Lancet Oncology, Vol. 9, No. 6, 01.06.2008, p. 585-595.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia

AU - Cunningham, Joan

AU - Rumbold, Alice

AU - Zhang, Xiaohua

AU - Condon, John R.

PY - 2008/6/1

Y1 - 2008/6/1

N2 - An assessment of recent data on cancer in Indigenous Australians (Aborigines and Torres Strait Islanders) shows that, although they are less likely to have some types of cancer than other Australians, Indigenous people are significantly more likely to have cancers that have a poor prognosis, but are largely preventable, such as lung and liver cancer. Indigenous people with cancer are diagnosed at a later stage, are less likely to receive adequate treatment, and are more likely to die from their cancers than other Australians. Inadequate identification of Indigenous people in cancer registers precludes reporting for some parts of Australia, but sufficient information is available to identify priorities and inform appropriate remedial action. Health-risk factors, especially smoking, and inadequate health-system performance largely explain the patterns of cancer incidence and mortality in areas with adequate data. Effective tobacco control programmes, improvements across a range of health services, and meaningful Indigenous engagement are all needed to decrease the burden of cancer in Indigenous Australians.

AB - An assessment of recent data on cancer in Indigenous Australians (Aborigines and Torres Strait Islanders) shows that, although they are less likely to have some types of cancer than other Australians, Indigenous people are significantly more likely to have cancers that have a poor prognosis, but are largely preventable, such as lung and liver cancer. Indigenous people with cancer are diagnosed at a later stage, are less likely to receive adequate treatment, and are more likely to die from their cancers than other Australians. Inadequate identification of Indigenous people in cancer registers precludes reporting for some parts of Australia, but sufficient information is available to identify priorities and inform appropriate remedial action. Health-risk factors, especially smoking, and inadequate health-system performance largely explain the patterns of cancer incidence and mortality in areas with adequate data. Effective tobacco control programmes, improvements across a range of health services, and meaningful Indigenous engagement are all needed to decrease the burden of cancer in Indigenous Australians.

UR - http://www.scopus.com/inward/record.url?scp=44249092282&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(08)70150-5

DO - 10.1016/S1470-2045(08)70150-5

M3 - Review article

VL - 9

SP - 585

EP - 595

JO - The Lancet Oncology

T2 - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 6

ER -